13 January 2026
Zoom
NICE has received an appeal against the Final Draft Guidance on the above technology from the following organisations:
- Eisai Europe Limited
The appeal panel will convene on Tuesday 13 January 2026 at 10:00am to hear oral representations from the appellants. This will be a virtual appeal hearing webinar via the secure online conferencing tool, Zoom.
Please read this important information on how to register for the webinar
- Click on the register link at the bottom of the page and complete the Zoom registration form. Please register with your full name as this is how it will be displayed during the hearing.
- You must use the email address that you are registering with to join the hearing. Please ensure you type in the correct address. Also check that if you are using a work email address, that it supports the use of Zoom. If in doubt, use a personal email address.
- Registration will close at 4:00pm on Tuesday 6 January 2026.
- You will receive your invitation and joining link for the webinar via email once registration has closed. You will be able to add the link to your calendar.
- You will be sent reminders up to an hour before the start of the webinar.
- We may not be able to accept any late requests or name changes after registration closes.
- As a public observer, you will be able to listen to the business of the hearing, however, you will not be able to participate in the discussions or ask questions or put your views to the members of the appeal panel.
- Should you have any queries regarding observing this hearing, please contact the corporate office.
Privacy statement – These meetings are being held via Zoom either as a meeting or webinar and your name, email and IP address will be processed. We ask for this data to help facilitate the event and monitor attendance. We may also ask you to share any accessibility needs that would support you during the virtual meeting. If the web meeting you are attending offers an interactive poll or Q&A session, participation is not mandatory, however your name may be processed with your poll responses and questions. We store this information in Zoom for 6 months, after which it is automatically deleted. After you have attended a meeting, we may also send you a feedback form so you can tell us about your experience and help us make any improvements. The feedback is anonymous and you cannot be identified. Further information about how we manage personal data at NICE can be found on our privacy notice – https://www.nice.org.uk/privacy-notice
REGISTRATION IS OPEN
Register here: Appeal against the FDG: Lecanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer’s disease [ID4043]
You will be registering directly for the webinar on Zoom so please make sure you note the meeting date and time in your diary. You will receive confirmation with your joining links and further information once registration has closed.
Registration will close at 4:00pm on Tuesday 6 January 2026.